Dr Reddys Laboratories Share Price Today - Live Blog for May 20, 2025

The share price of Dr Reddys Laboratories Ltd plunged by -0.17%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,222.90, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.27%, reaching the current market price of ₹1,225.90. This development underscores the stock's growing popularity.

With a -0.28% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,223.10. The stock is currently trading at a PE of 17.9800, while the industry PE is 33.8128, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.12%, and as of now, it's trading at ₹1,226.55 per share. This upward trajectory is attracting keen interest from investors.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.33%, reaching the current market price of ₹1,223.90. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

After a -0.21% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,221.40. The stock has a PE ratio of 17.9800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.53%, a situation worth noting. At present, the stock is trading at ₹1,223.45. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.9800, while the industry PE ratio is 33.8128.

Dr Reddys Laboratories Ltd's share price remained flat, currently at ₹1,230.00. This sustained performance provides investors with an opportunity to assess whether the stock aligns with their investment objectives.

The stock of Dr Reddys Laboratories Ltd suffered a -0.14% decline, and it currently trades at ₹1,230.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Dr Reddys Laboratories Ltd plunged by -0.05%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,229.80, but investors are assessing whether this is a temporary dip or a long-term trend.

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,229.75. This development raises questions about the factors behind the decline. The stock's PE ratio is 17.9800, while the industry PE is 33.8128.

Dr Reddys Laboratories Ltd experienced a -0.10% dip in its share price and is currently trading at ₹1,229.75. The stock has a PE ratio of 17.9800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.03% upswing and is currently trading at ₹1,230.75, indicating strong market sentiment.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.13%, signalling a challenging period. Currently trading at ₹1,230.45, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.23% gain, with the share price now at ₹1,232.50. Notably, the stock's PE ratio stands at 17.9800, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd witnessed a -0.09% drop in its share price and is currently trading at ₹1,229.70. With the stock's PE at 17.9800 and the industry PE at 33.8128, investors are weighing their options.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.02%, reaching the current market price of ₹1,230.80. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.09%, a situation worth noting. At present, the stock is trading at ₹1,231.20. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.9800, while the industry PE ratio is 33.8128.

Dr Reddys Laboratories Ltd observed a remarkable 0.16% surge in its share price and is presently trading at ₹1,232.70. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd experienced a -0.05% downturn in its share price, and it's currently trading at ₹1,231.00. This situation is generating interest among value investors who are evaluating the stock's potential.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.05% in its share price, and it currently trades at ₹1,230.60 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.15%, with its current market value per share resting at ₹1,230.60. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's share price rallied by 0.09%, reaching the current market price of ₹1,227.00. This surge is indicative of the stock's recent positive performance.

The stock of Dr Reddys Laboratories Ltd suffered a -0.02% drop, and it's now trading at ₹1,225.45 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd share price surged by 0.11%. With its current market price standing at ₹1,225.40 per share, this stock is garnering increased attention from the investment community.

The stock of Dr Reddys Laboratories Ltd is facing a -0.89% decline and is currently trading at ₹1,224.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.